XML 50 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Capital Stock (Tables)
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Stock Compensation

 

Three Months Ended

 

 

March 31,

 

(In Thousands of U.S. Dollars)

2021

 

 

2020

 

Cost and expenses applicable to revenues

$

 

294

 

 

$

 

400

 

Selling, general and administrative expenses

 

 

4,944

 

 

 

 

3,707

 

Research and development

 

 

69

 

 

 

 

85

 

 

$

 

5,307

 

 

$

 

4,192

 

 

Stock-based Compensation by Plan Type

The following table summarizes the Company’s share-based compensation expense by each award type:

 

 

Three Months Ended

 

 

March 31,

 

(In Thousands of U.S. Dollars)

2021

 

 

2020

 

Stock Options

$

 

351

 

 

$

 

513

 

Restricted Share Units

 

 

3,151

 

 

 

 

2,902

 

Performance Stock Units

 

 

1,014

 

 

 

 

279

 

IMAX China Stock Options

 

 

56

 

 

 

 

85

 

IMAX China Long Term Incentive Plan Restricted Share Units

 

 

632

 

 

 

 

405

 

IMAX China Long Term Incentive Plan Performance Stock Units

 

 

103

 

 

 

 

8

 

 

$

 

5,307

 

 

$

 

4,192

 

Schedule of Share-based Compensation, Stock Options, Activity

The following table summarizes the activity under the Company’s Stock Option Plan (“SOP”) and IMAX Corporation Second Amended and Restated Long-Term Incentive Plan (as may be amended, “IMAX LTIP”) for the three months ended March 31, 2021 and 2020:

 

 

 

Number of Shares

 

 

 

Weighted Average Exercise

Price Per Share

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Stock options outstanding, beginning of period

 

 

4,892,962

 

 

 

5,732,209

 

 

$

 

26.81

 

 

$

 

26.82

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(38,754

)

 

 

 

 

 

 

21.26

 

 

 

 

 

Forfeited

 

 

(44,362

)

 

 

(14,876

)

 

 

 

23.12

 

 

 

 

21.78

 

Expired

 

 

(885,698

)

 

 

(772,665

)

 

 

 

28.31

 

 

 

 

27.03

 

Cancelled

 

 

(10,917

)

 

 

(591

)

 

 

 

27.20

 

 

 

 

20.85

 

Stock options outstanding, end of period

 

 

3,913,231

 

 

 

4,944,077

 

 

 

 

26.56

 

 

 

 

26.80

 

Stock options exercisable, end of period

 

 

3,615,079

 

 

 

4,331,193

 

 

 

 

26.93

 

 

 

 

27.32

 

Restricted Stock Units Activity under the IMAX LTIP

The following table summarizes the activity in respect of RSUs issued under the IMAX LTIP for the three months ended March 31, 2021 and 2020:

 

 

 

Number of Awards

 

 

Weighted Average Grant Date

Fair Value Per Share

 

 

 

2021

 

 

2020

 

 

 

2021

 

 

 

2020

 

RSUs outstanding, beginning of period

 

 

1,564,838

 

 

 

1,065,347

 

 

$

 

18.33

 

 

$

 

23.17

 

Granted

 

 

754,778

 

 

 

937,303

 

 

 

 

20.94

 

 

 

 

15.65

 

Vested and settled

 

 

(523,573

)

 

 

(295,063

)

 

 

 

18.82

 

 

 

 

23.96

 

Forfeited

 

 

(60,329

)

 

 

(15,521

)

 

 

 

20.08

 

 

 

 

21.64

 

RSUs outstanding, end of period

 

 

1,735,714

 

 

 

1,692,066

 

 

 

 

19.26

 

 

 

 

18.88

 

Performance Stock Units Activity under the IMAX LTIP

The following table summarizes the activity in respect of PSUs issued under the IMAX LTIP for the three months ended March 31, 2021 and 2020:

 

 

Number of Awards

 

 

Weighted Average Grant Date

Fair Value Per Share

 

 

 

2021

 

 

2020

 

 

 

2021

 

 

 

2020

 

PSUs outstanding, beginning of period

 

 

361,844

 

 

 

 

 

$

 

15.68

 

 

$

 

 

Granted

 

 

308,438

 

 

 

359,784

 

 

 

 

20.77

 

 

 

 

15.74

 

Forfeited

 

 

(2,526

)

 

 

 

 

 

 

14.84

 

 

 

 

 

PSUs outstanding, end of period

 

 

667,756

 

 

 

359,784

 

 

 

 

18.03

 

 

 

 

15.74

 

 

As of March 31, 2021, the maximum number of shares of common stock that may be issued with respect to PSUs outstanding is 1,168,573, assuming full achievement of the EBITDA and TSR targets.

Basic and Diluted Per-share Computations

The following table reconciles the denominator of the basic and diluted weighted average share computations:

 

 

Three Months Ended

 

 

March 31,

 

 

2021

 

 

2020

 

(In thousands)

 

 

 

 

 

 

 

 

 

Issued and outstanding, beginning of period

 

 

58,921

 

 

 

 

61,176

 

Weighted average number of shares issued (repurchased), net

 

 

91

 

 

 

 

(758

)

Weighted average number of shares outstanding - basic

 

 

59,012

 

 

 

 

60,418

 

Weighted average effect of potential common shares, if dilutive

 

 

 

 

 

 

 

Weighted average number of shares outstanding - diluted

 

 

59,012

 

 

 

 

60,418